Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus

Correction to: Diabetes Ther (2019) 10:311–321 https://doi.org/10.1007/s13300-018-0555-5

In the original article, the 6th sentence of the section “FD and calorie intake” is incorrect. The correct sentence is “The protein component of FD consists of whey protein, casein, and soy protein”.

There is a correction in the “Inclusion criteria” section, the correct sentence is Estimated glomerular filtration rate (eGFR) ≥ 45 ml/min/1.73 m2.

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Author information

Correspondence to Ichiro Tatsuno.

Rights and permissions

This article is published under an open access license. Please check the 'Copyright Information' section for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Watanabe, Y., Kuribayashi, N., Uchida, D. et al. Correction to: Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus. Diabetes Ther 11, 753 (2020). https://doi.org/10.1007/s13300-020-00757-6

Download citation